PHARMACOKINETICS OF HALOPERIDOL

被引：119

作者：

FROEMMING, JS

LAM, YWF

JANN, MW

DAVIS, CM

机构：

[1] MERCER UNIV,SO SCH PHARM,DEPT PHARM PRACTICE,ATLANTA,GA

[2] UNIV TEXAS,HLTH SCI CTR,DIV CLIN PHARM,SAN ANTONIO,TX 78284

[3] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712

[4] UNIV TEXAS,INST MENTAL SCI INST,HOUSTON,TX 77025

来源：

关键词：

D O I：

10.2165/00003088-198917060-00004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：396 / 423

页数：28

共 153 条

[1] HALOPERIDOL DETERMINATION IN SERUM AND CEREBROSPINAL-FLUID USING GAS-LIQUID-CHROMATOGRAPHY WITH NITROGEN PHOSPHORUS DETECTION - APPLICATION TO PHARMACOKINETIC STUDIES
ABERNETHY, DR
GREENBLATT, DJ
OCHS, HR
WILLIS, CR
MILLER, DD
SHADER, RI
[J]. JOURNAL OF CHROMATOGRAPHY, 1984, 307 (01): : 194 - 199
[2] ALTAMURA C, 1988, PROG NEURO-PSYCHOPH, V12, P689
[3] ARANA GW, 1986, AM J PSYCHIAT, V143, P650
[4] AYD FJ, 1984, INT DRUG THER NEWSL, V19, P33
[5] Ayd Jr, 1978, INT DRUG THER NEWSL, V13, P20
[6] ADVERSE REACTIONS IN TREATMENT WITH LITHIUM-CARBONATE AND HALOPERIDOL
BAASTRUP, PC
HOLLNAGEL, P
SORENSEN, R
SCHOU, M
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (23): : 2645 - 2646
[7] ANTIPSYCHOTIC-DRUGS - CLINICAL PHARMACOKINETICS OF POTENTIAL CANDIDATES FOR PLASMA-CONCENTRATION MONITORING
BALANTGORGIA, AE
BALANT, L
[J]. CLINICAL PHARMACOKINETICS, 1987, 13 (02) : 65 - 90
[8] HALOPERIDOL DECANOATE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN PSYCHOSIS
BERESFORD, R
WARD, A
[J]. DRUGS, 1987, 33 (01) : 31 - 49
[9] BIANCHETTI G, 1980, INT J CLIN PHARM TH, V18, P324
[10] BIRKHIMER LJ, 1985, CLIN PHARMACY, V4, P425